Matrixyl

What Matrixyl does

Original Matrixyl is palmitoyl pentapeptide-4, a peptide used in skin creams. Small human studies suggest modest wrinkle changes, but many tested mixtures. Matrixyl 3000 and Synthe’6 contain different peptides. Short studies found few skin complaints; long-term and pregnancy safety remain uncertain.

• In a 12-week trial, a 3 ppm cream improved how wrinkles looked compared with the same moisturizer without it. (Studied in a trial)
• In a small study, creams that contained it among other ingredients made skin smoother; its own share is unclear. (Studied in a trial)
• In lab studies, it increased collagen production in cells. (animal)
• One user reported a subtle improvement in skin texture and bounce after 6–8 weeks of use, mostly at night. (Reported by users)

Uses in the sources

• Studied topically for visible fine lines and wrinkles. The best-known trial compared 3 ppm cream with a matching moisturizer for 12 weeks. (Studied in a trial) (source)
• A mixed cream was studied during breast radiotherapy and showed no advantage over dexpanthenol lotion. (Studied in a trial) (source)

Matrixyl dosage

Typical reported dose: A serum at night; amount not reported

• 3 ppm moisturizer, twice daily: About 0.4 g finished moisturizer per half-face twice daily, on the skin. Studied in a trial. Studied in: Adults in the cited study; see study population. (source)
• Eye cream, strength undisclosed: One fingertip unit, stated as 0.5 g cream twice daily, on the skin. Studied in a trial. Studied in: Adults in the cited study; see study population. (source)
• Patent cream, 50 ppm: 0.005% pal-KTTKS cream; mass unknown twice daily, on the skin. Studied in a trial. Studied in: Adults in the cited study; see study population. (source)
• Conference moisturizer, 3 ppm: 3 ppm pal-KTTKS moisturizer; amount unknown twice daily, on the skin. Studied in a trial. Studied in: Adults in the cited study; see study population. (source)
• Older four-month cream study: Pal-KTTKS cream; strength and amount unknown twice daily, on the skin. Studied in a trial. Studied in: Adults in the cited study; see study population. (source)
• Older 3 ppm retinol comparison: 3 ppm pal-KTTKS cream; amount unknown not stated in retrieved account, on the skin. Studied in a trial. Studied in: Adults in the cited study; see study population. (source)

These are doses reported in labels, trials or user reports, not a personal plan. Check the source behind each one.

Work out syringe units with the dosing calculator

How to mix Matrixyl

Comes as: Finished topical creams, moisturizers and serums, Raw cosmetic ingredient mixtures or powder; not established for injection.

Mixed with: No injectable diluent is established. Do not add water to a finished cosmetic..

• Form evidence is from topical trials; general hygiene notes come from FDA cosmetic guidance.
• Trials used formulated creams, not reconstituted injection vials.
• No verified community vial size or bacteriostatic-water recipe found.

Before mixing: No universal storage schedule. Follow finished-product storage directions and expiry.

After mixing: No validated home-mixed shelf life. Keep containers clean; warm or damp storage can weaken preservation.

Matrixyl side effects and risks

Reported side effects

• Skin redness or irritation: Patch mixture: slight redness in 1/10; cream complaints 0/7 in the 8 week trial., mild. Stop for persistent burning or rash. Other ingredients may be responsible. (source)
• Allergic skin reaction: One suspected allergy in a 20 person mixed cream trial; arm denominator unavailable., moderate. Stop and seek assessment for swelling, hives or a spreading rash. (source)
• Serious allergic reaction: General cosmetic risk; no pal KTTKS specific rate established., serious. Breathing trouble or throat swelling needs emergency care. (source)

Stop and get help if

• Wheezing, throat or tongue swelling, faintness with hives: Stop use and get emergency care now.
• Spreading rash, marked facial swelling or persistent burning: Stop the product and seek prompt medical assessment.

Who should avoid it

• pregnant: Pregnancy safety is unstudied; pregnant participants were excluded. This is a precaution.
• breastfeeding: Breastfeeding safety is unstudied; breastfeeding participants were excluded. This is a precautionary block.
• tryingToConceive: Those trying to conceive were excluded from the 2023 trial; reproductive safety is unknown.
• under18: Trials enrolled adults. Safety and benefit under 18 are unestablished.
• other: Known allergy to an ingredient can recur with exposure.
• other: The trial excluded damaged test skin and recent resurfacing. Cosmetic results do not establish use through needles.
• activeCancer: For cancer or radiotherapy at the application site, coordinate skin care with oncology. A mixed-cream trial showed no advantage.
• testedAthlete: No Matrixyl-specific WADA ruling found. Confirm the exact product and route with your anti-doping authority.

Interactions

• Topical retinoids: A trial used retinyl propionate in a mixed regimen. It did not test Matrixyl plus tretinoin or establish a layering interaction.
• Other Matrixyl or multi-peptide products: Different peptides share Matrixyl names. A blend percentage cannot be converted to a pal-KTTKS dose from an ingredient list.

Product quality risks

• A blend percentage is not pure-peptide strength. Later Matrixyl generations contain different peptides.
• Formulation changes peptide availability; an ingredient list cannot confirm an effective concentration.
• Poor manufacturing, storage or preservation can contaminate creams. This is a general cosmetic risk.

What to expect

A 12-week split-face study tested a topical cream with 3 ppm pal-KTTKS; its findings do not cover all Matrixyl blends.

15 reported human investigations, including mixtures and patch tests. Older supplier cohorts may overlap; the evidence for isolated peptide effects remains limited.

Key studies

• 2005: 3 ppm wrinkle trial: A 3 ppm cream improved wrinkle appearance versus its matching moisturizer. (source)
• 2023: crow's feet comparison: Scores fell in all groups; this small trial did not establish superiority. (source)
• Patent: 50 ppm cream: A patent reports wrinkle changes with 50 ppm cream and limited methods. (source)
• 2005: moisturizer conference abstract: An abstract reports texture changes with a mixed 3 ppm moisturizer. (source)
• Older study: 49 women: A review reports wrinkle and biopsy changes; original data were not recovered. (source)
• Older study: retinol comparison: A review reports similar changes to retinol; equivalence was not established. (source)

Matrixyl FAQ

• Is Matrixyl FDA-approved? No FDA-approved therapeutic product located. Cosmetic appearance claims differ from collagen-production drug claims. DailyMed listing alone is not approval.
• How do people take it? On the skin, mostly at night; days per week unstated. Reported 6–8 weeks. Source: reported by users, not an established dose.
• What's the difference between Matrixyl and Argireline? Matrixyl: a topical cosmetic peptide with limited human evidence for making fine lines less visible. Argireline: a topical cosmetic peptide with small, mixed wrinkle studies and limited skin penetration. Why people pair them: users combine wrinkle-focused peptides in one cream. No trial isolates added benefit from this pairing.
• Can I take it with Acetylhexapeptide-8? Users combine wrinkle-focused peptides in one cream. No trial isolates added benefit from this pairing. Multiple ingredients make benefits and irritation hard to attribute. Source: reported by users. Ask a doctor before combining anything.
• Is it banned in sport? It is unclear (WADA 2026). Matrixyl and pal-KTTKS are not named. S0 covers unapproved pharmacological substances; no specific cosmetic ruling found.
• How long does a mixed vial last? No validated home-mixed shelf life. Keep containers clean; warm or damp storage can weaken preservation.